Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-02-16 Sale | 2024-02-20 4:05 pm | Deciphera Pharmaceuticals Inc. | DCPH | Pitman Jama SVP, Chief Development Officer | 2,267 | $15.62 | $35,405 | 106,931 (Direct) | View |
| 2024-01-16 Sale | 2024-01-18 4:15 pm | Deciphera Pharmaceuticals Inc. | DCPH | Pitman Jama SVP, Chief Development Officer | 1,624 | $14.47 | $23,499 | 50,573 (Direct) | View |
| 2023-12-13 Sale | 2023-12-14 4:05 pm | Deciphera Pharmaceuticals Inc. | DCPH | Pitman Jama See Remarks | 1,662 | $15.37 | $25,540 | 52,197 (Direct) | View |
| 2023-10-30 Sale | 2023-10-31 4:10 pm | Deciphera Pharmaceuticals Inc. | DCPH | Pitman Jama See Remarks | 1,407 | $12.02 | $16,909 | 48,283 (Direct) | View |
| 2023-06-16 Sale | 2023-06-21 4:05 pm | Deciphera Pharmaceuticals Inc. | DCPH | Pitman Jama See Remarks | 1,238 | $14.4 | $17,829 | 43,812 (Direct) | View |
| 2023-02-16 Sale | 2023-02-17 4:14 pm | Deciphera Pharmaceuticals Inc. | DCPH | Pitman Jama See Remarks | 1,159 | $15.1 | $17,500 | 89,650 (Direct) | View |
| 2023-01-17 Sale | 2023-01-19 4:06 pm | Deciphera Pharmaceuticals Inc. | DCPH | Pitman Jama See Remarks | 1,603 | $21.24 | $34,050 | 35,058 (Direct) | View |
| 2022-06-16 Sale | 2022-06-21 4:36 pm | Deciphera Pharmaceuticals Inc. | DCPH | Pitman Jama See Remarks | 1,298 | $10.75 | $13,954 | 36,661 (Direct) | View |
| 2022-02-16 Sale | 2022-02-18 5:00 pm | Deciphera Pharmaceuticals Inc. | DCPH | Pitman Jama See Remarks | 1,146 | $9.05 | $10,371 | 37,959 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-02-15 Option Award | 2024-02-20 4:05 pm | N/A 2034-02-14 | Deciphera Pharmaceuticals Inc. | DCPH | Pitman Jama SVP, Chief Development Officer | 58,625 | $0 | 106,931 (Direct) | View |
| 2023-12-12 Option Award | 2023-12-14 4:05 pm | N/A N/A | Deciphera Pharmaceuticals Inc. | DCPH | Pitman Jama See Remarks | 5,576 | $0 | 52,197 (Direct) | View |
| 2023-10-28 Option Award | 2023-10-31 4:10 pm | N/A N/A | Deciphera Pharmaceuticals Inc. | DCPH | Pitman Jama See Remarks | 5,576 | $0 | 48,283 (Direct) | View |
| 2023-02-15 Option Award | 2023-02-17 4:14 pm | N/A 2033-02-14 | Deciphera Pharmaceuticals Inc. | DCPH | Pitman Jama See Remarks | 55,751 | $0 | 89,650 (Direct) | View |
| 2022-01-18 Option Award | 2022-01-20 5:00 pm | N/A 2032-01-17 | Deciphera Pharmaceuticals Inc. | DCPH | Pitman Jama See Remarks | 68,334 | $0 | 93,772 (Direct) | View |
| 2021-12-15 Option Award | 2021-12-17 4:10 pm | N/A 2031-12-14 | Deciphera Pharmaceuticals Inc. | DCPH | Pitman Jama See Remarks | 71,271 | $0 | 88,409 (Direct) | View |
Ownership | 2021-04-02 5:58 pm | N/A N/A | Deciphera Pharmaceuticals Inc. | DCPH | Pitman Jama SVP, Regulatory & Quality | 0 | $0 | 164,725 (Direct) | View |